Exotech Bio's Corporate Minority Round

Exotech Bio raised a round of funding on April 11, 2016. Investors include Intrexon.

Exotech Bio is a San Francisco-based biotechnology utilizing a novel exosome-based platform for delivering therapeutic RNA to treat select cancer indications.…

Articles about Exotech Bio's Corporate Minority Round: